NR4A1 and neoplasm: Patients with ≥ 2 CTCs per 7.5 mL at baseline had gene expression profiles in tumor suggestive of increased T‐cell activity, including increased tumor inflammation signature (TIS) in both triple‐negative (P = 0.010) and hormone receptor‐positive (P = 0.024) disease.